# [F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis

> **NCT01602471** · PHASE2 · TERMINATED · sponsor: **Siemens Molecular Imaging** · enrollment: 5 (actual)

## Conditions studied

- Carotid Stenosis

## Interventions

- **DRUG:** [F-18]RDG-K5

## Key facts

- **NCT ID:** NCT01602471
- **Lead sponsor:** Siemens Molecular Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Sponsor decided to develop the product in collaboration
- **Last updated:** 2013-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01602471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01602471, "[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01602471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*